← FDA DRUG APPROVALS

FDA NDA · NDA202860

GENOSYL

nitric oxide

Sponsor: VERO BIOTECH INC

APPLICATION
NDA202860
TYPE
NDA
ORIGINAL APPROVAL
2019-12-20
LATEST ACTION
2019-12-20
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
GAS
MARKETING STATUS
Prescription

Products

GENOSYL · ReferencePrescription
NITRIC OXIDE 800PPM · GAS · INHALATION

Approval history

2019-12-20Type 5 - New Formulation or New Manufacturer · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →